DEXYCU Drug Patent Profile
✉ Email this page to a colleague
When do Dexycu patents expire, and what generic alternatives are available?
Dexycu is a drug marketed by Eyepoint Pharms and is included in one NDA. There are five patents protecting this drug.
The generic ingredient in DEXYCU is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexycu
A generic version of DEXYCU was approved as dexamethasone by PANGEA on April 28th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DEXYCU?
- What are the global sales for DEXYCU?
- What is Average Wholesale Price for DEXYCU?
Summary for DEXYCU
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for DEXYCU |
| What excipients (inactive ingredients) are in DEXYCU? | DEXYCU excipients list |
| DailyMed Link: | DEXYCU at DailyMed |
US Patents and Regulatory Information for DEXYCU
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | 10,028,965 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | 10,799,642 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | 11,097,061 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Eyepoint Pharms | DEXYCU KIT | dexamethasone | SUSPENSION;INTRAOCULAR | 208912-001 | Feb 9, 2018 | RX | Yes | Yes | 10,022,502 | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
